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Key points:  
• The 4AT is a short delirium assessment tool that is widely used internationally in clinical 
practice. 
• This systematic review and meta-analysis of diagnostic accuracy studies of the 4AT 
included 3702 observations in 17 studies from nine countries. 
• Studies recruited from a range of settings including the Emergency Department, and 
medical, stroke, and surgical wards. 
• The 4AT had a pooled sensitivity of 0.88 and pooled specificity of 0.88.  
• The methodological quality of studies varied but was moderate to good overall. 
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Objective: Detection of delirium in hospitalised older adults is recommended in national and 
international guidelines. The 4 ‘A’s Test (4AT) is a short (<2 min) instrument for delirium 
detection that is used internationally as a standard tool in clinical practice. We performed a 
systematic review and meta-analysis of diagnostic test accuracy of the 4AT for delirium 
detection. 
 
Methods: We searched MEDLINE, EMBASE, PsycINFO, CINAHL, clinicaltrials.gov and the 
Cochrane Central Register of Controlled Trials, from 2011 (year of 4AT release on the website 
www.the4AT.com) until 21 December 2019. Inclusion criteria were: older adults (≥65y); 
diagnostic accuracy study of the 4AT index test when compared to delirium reference standard 
(standard diagnostic criteria or validated tool). Methodological quality was assessed using the 
Quality Assessment of Diagnostic Accuracy Studies-2 tool. Pooled estimates of sensitivity and 
specificity were generated from a bivariate random effects model. 
 
Results: 17 studies (3702 observations) were included. Settings were acute medicine, surgery, 
a care home, and the emergency department. Three studies assessed performance of the 4AT 
in stroke. The overall prevalence of delirium was 24.2% (95% CI 17.8-32.1%; range 10.5-
61.9%). The pooled sensitivity was 0.88 (95% CI 0.80-0.93) and the pooled specificity was 0.88 
(95% CI 0.82-0.92). Excluding the stroke studies, the pooled sensitivity was 0.86 (95% CI 0.77-
0.92) and the pooled specificity was 0.89 (95% CI 0.83-0.93). The methodological quality of 
studies varied but was moderate to good overall. 
 
Conclusions: The 4AT shows good diagnostic test accuracy for delirium in the 17 available 
studies. These findings support its use in routine clinical practice in delirium detection.  
 
PROSPERO Registration number CRD42019133702. 
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Delirium is a serious acute neuropsychiatric disorder of consciousness, attention and cognition 
triggered by general medical conditions, drugs, surgery, or a combination of causes. It 
manifests through acute and fluctuating cognitive, psychomotor and perceptual disturbances 
which develop over hours to days [1]. Delirium is common in hospitalised older adults, with a 
recent meta-analysis of 33 studies of medical inpatients finding an overall delirium occurrence 
of 23% (95% CI 19-26%) [2]. It is also common in surgical patients, in care homes and palliative 
care settings [3]. Delirium is associated with significant adverse outcomes including functional 
decline and mortality, and patient and carer distress [4, 5]. 
 
Detection of delirium at the earliest possible time point is important for several reasons, 
including prompting the search for acute triggers, gaining access to recommended treatment 
pathways, in managing delirium-associated risks such as falls, in identifying and treating 
distress, in providing prognostic information, and in communicating the diagnosis to patients 
and carers. Detection has been recommended in multiple guidelines including the Scottish 
Intercollegiate Guidelines Network (SIGN) guidelines on delirium [6]. More than 30 delirium 
assessment tools exist, though these vary considerably in purpose and clinical applicability [7, 
8]. Categories of tools include: those intended for episodic use at first presentation or at other 
points when delirium is suspected; regular use (that is, daily or more frequently) in monitoring 
for new onset delirium in inpatients; ‘ultra-brief’ screening tools; intensive care unit tools; 
measurement of delirium severity; informant-based; and detailed phenomenological 
assessment.  
 
The 4 ‘A’s Test or 4AT was developed as a short delirium assessment tool intended for clinical 
use in general settings at first presentation and when delirium is suspected. It was initially 
published on a dedicated website in 2011 [9]. It consists of four items: an item assessing level 
  
of alertness, a test of orientation (the Abbreviated Mental Test–4, comprising 4 orientation 
questions), a test of attention (Months Backward test); and an item ascertaining acute change 
or fluctuating course [Appendix 1]. The first diagnostic test accuracy study in general settings 
was published in 2014 [10]. Since publication 4AT performance has been evaluated in multiple 
studies [11]. The 4AT has become a standard tool in clinical practice [12, 13] and it is 
recommended in guidelines and pathways [6, 14]. 
 
Here we report a systematic review and meta-analysis of studies that have evaluated the 






The methods and search strategy were documented in advance and published in the 
PROSPERO database (available at http://www.crd.york.ac.uk/PROSPERO/ with registration 
number CRD42019133702). The review and meta-analysis were conducted in compliance with 
the principles in the Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy 
[15], and reported using the Preferred Reporting Items for a Systematic Review and Meta-
analysis of Diagnostic Test Accuracy Studies (PRISMA-DTA) guidelines [16]. 
Search strategy and selection criteria 
An inclusive search strategy was developed with a medical librarian. The validated delirium 
search syntax produced by the National Institute for Health and Clinical Excellence (NICE) 
clinical guidance for delirium was used to identify delirium [Appendix 2: search strategy]. The 
following databases were searched: MEDLINE® (OVID), EMBASE (OVID), PsycINFO 
(EBSCO), CINAHL (EBSCO), clinicaltrials.gov and the Cochrane Central Register of Controlled 
trials from 2011 (the year the 4AT was published online) to 21 December 2019. We conducted 
forward citation searches of included articles and checked reference lists of included articles for 
further articles of potential relevance. We contacted delirium experts from international delirium-
focused organisations to identify relevant published or unpublished data and searched relevant 
conference proceedings. 
Studies were included if they met the following criteria: (1) age ≥65; (2) examined the 
diagnostic accuracy of the 4AT for detection of delirium; (3) reference standard assessment of 
delirium made using standardised diagnostic criteria or a validated tool; and (4) cross-sectional, 
retrospective or prospective cohort design. If identified studies included adults both younger and 
older than the threshold age, the study authors were contacted to enquire about the possibility 




Titles and abstracts were independently screened for inclusion by individuals in pairs of review 
authors (C.B. and R.G., and Z.T. and A.A.). Full-text screens were carried out independently by 
two review authors (Z.T. and A.M.). The reviewer pairs performed data extraction 
independently, resolving disagreement by discussion, or by involving another review author 
(S.S.) where necessary. 
Data were extracted on: type of study; setting; study population; patient demographics; 
prevalence of delirium; co-morbid illness or illness severity if reported; details of 4AT 
administration (timing, assessors etc.) and the reference standard; statistics used including 
adjustments made; and study conclusions. Test accuracy data were extracted to a two-by-two 
table (number of true positives, false positives, true negatives and false negatives for the 4AT). 
Study authors were contacted for further information on index and reference test results if 
insufficient data were provided to perform statistical analyses. 
Risk of bias assessment 
Studies were assessed for methodological quality by two independent review authors (R.G. and 
Z.T.) using the Quality Assessment of Diagnostic Accuracy Studies (QUADAS-2) tool. Narrative 
summaries were generated describing risk of bias (high, low, or unclear) and concerns 
regarding applicability. As part of a tailoring phase of the QUADAS-2 tool, the item on the 
threshold used was omitted because the design of the 4AT pre-specifies the threshold to be 
used for delirium detection (cut-off ≥ 4). For the item on the appropriate interval between index 
test and reference standard, the interval was set to a maximum of three hours [Appendix 3: 
Assessment of methodological quality with the QUADAS-2 tool]. 
Statistical analysis 
Meta-analyses were completed using Diagnostic Test Accuracy Meta-Analysis software, 
version 1.21 (https://crsu.shinyapps.io/dta_ma/) [17]. Pooled estimates of delirium prevalence 
were calculated using random effects models (meta package in R [18]). No continuity correction 
  
was applied. The primary outcome of interest was the identification of delirium (presented as a 
dichotomous yes/no variable) by a reference standard (i.e. Diagnostic and Statistical Manual of 
Mental Disorders (DSM)) or a validated diagnostic tool such as the Confusion Assessment 
Method (CAM) [19]. Summary estimates of sensitivity and specificity with 95% confidence 
intervals (CI) were calculated using a bivariate random effects model. Receiver operating 
characteristic (ROC) curves were used to plot summary estimates of sensitivity and specificity. 
A sensitivity analysis was performed including only those studies which were deemed to 
have an overall low risk of bias (that is, high study quality). A further sensitivity analysis was 
conducted excluding retrospective studies, because these are prone to selection bias [20]. Pre-
planned subgroup analyses were also conducted to investigate clinical heterogeneity across 
studies: (i) excluding studies in patients with stroke, because of the potential influence of 
aphasia on the test [21, 22], to assess test accuracy of the 4AT in non-stroke populations, and 
(ii) analysing separately for studies using (a) a clinical reference standard (e.g. DSM) or (b) a 
validated assessment tool (e.g. the Confusion Assessment Method (CAM)). A post-hoc 
subgroup analysis was conducted to compare diagnostic accuracy of the English 4AT versus 





We identified 853 records from our initial search and 3 records from conference abstracts 
(Figure 1). A total of 780 records remained after initial deduplication. Following title and abstract 
screening, 21 records had full-text review and 16 articles were included reporting 17 different 
studies [10, 11, 23-36]. The main reason for exclusion of articles was that studies were not 
designed as a diagnostic accuracy study of the 4AT and/or did not include data that allowed 
derivation of diagnostic test accuracy data. One conference proceeding reported two separate 
studies [26]. Three authors provided study data on subgroups of older patients [24, 28, 31, 37]. 
Study characteristics 
A summary of the characteristics of the included studies is provided in Table 1. The number of 
study participants ranged between 49 [27] and 785 [11]. The prevalence of delirium across the 
studies was 24.2% (95% CI 17.8-32.1%), varying between 10.5% [37] to 61.9% [29]. Eight 
studies validated a translated version of the 4AT in Italian, Persian, Thai, Russian, French, 
Norwegian and German [10, 23, 25, 27, 28, 30-32]. Two studies used a modified 4AT where the 
months of the year backwards test was replaced by the days of the week backwards to assess 
inattention [26, 33]; this modification does not affect the threshold scoring for delirium versus no 
delirium in the tool. Studies were conducted in inpatient general medical or geriatric medical 
wards, acute stroke units, emergency departments and post-operative care units, and nursing 
homes, in eleven countries. In one study in Australia, 39% of participants were non-English 
speakers and required an interpreter during the assessment [29]. 
Study quality 
The methodological quality of studies varied but was moderate to good overall. Potential for 
bias in studies was generally low, but where present was due to the selection of participants 
(e.g., excluding patients unable to give consent or those with dementia, n=2), the timing 
  
between the reference standard assessment and the 4AT (not reported (n=6) or exceeding the 
maximum interval of 3 hours (n=2)), and the blinding of assessments (unblinded raters (n=2) or 
blinding status unclear (n=3)) (Table 1 and Figure 2). Seven papers were of higher concern 
(rated high or unclear risk of bias across three areas), including 4 retrospective studies which 
are generally considered to be of higher risk of bias. Nine studies were considered low risk 
overall. 
Myrstad et al. [27] used a reference standard based on the whole length of stay (median 
5 days) whereas the 4AT was performed in the first 24 hours of the admission; this could have 
led to a reduced sensitivity of the 4AT as some delirium arises after the first 24 hours. Hendry et 
al. [36] administered the 4AT as part of a larger cognitive test battery, therefore the index rater 
had knowledge of the participant’s mental status beyond that elicited by the 4AT assessment 
that could have affected 4AT scoring. Gagné et al. [25] repeatedly administered the 4AT and 
the combined results were incorporated in the reported sensitivity and specificity. Asadollahi et 
al. [23] administered the 4AT only to those patients who had delirium according to DSM-5 
criteria. 
Diagnostic test accuracy 
All 17 studies were included in the meta-analysis. The 4AT had a pooled sensitivity for detecting 
delirium of 0.88 (95% CI 0.80-0.93) and a pooled specificity of 0.88 (95% CI 0.82-0.92), 
indicating good diagnostic accuracy of the 4AT as a tool to identify individuals at high risk of 
delirium (Table 2 and Figure 3). These estimates were broadly consistent across studies with 
the exception of two studies reporting lower sensitivities (both studies had a high or unclear risk 
of bias) [23, 27]. Sensitivity analyses showed comparable summary estimates of sensitivity 
(0.87, 95% CI 0.84-0.90) and specificity (0.88, 95% CI 0.81-0.93) when analysing studies with 
overall low risk of bias (9 studies), and also when excluding the four retrospective studies 
(sensitivity: 0.87, 95% CI 0.78-0.92; specificity: 0.87, 95% CI 0.79-0.92) [Appendix 4]. 
The planned subgroup analysis excluding three studies in stroke patients resulted in 
similar summary estimates of sensitivity (0.86; 95% CI 0.77-0.92) and specificity (0.89; 95% CI 
  
0.83-0.93), suggesting robust results across populations (results of the other subgroup analyses 
are presented in Appendix 5]. Three studies reported findings in subsets of patients with known 
dementia, with sensitivities of 0.94, 0.86, and 0.92 and specificities of 0.65, 0.71, and 0.79, in 






Statement of principal findings 
This systematic review identified 17 studies involving 3702 observations evaluating the 
diagnostic test accuracy of the 4AT for detection of delirium in older patients (≥65y) across 
eleven countries, a variety of care settings and in multiple languages. The prevalence of 
delirium was 24.2% (N=945), ranging from 10.5%-61.9%. Pooled sensitivity and specificity were 
0.88 and 0.88, respectively, indicating good accuracy. Notably, the sensitivity and specificity 
were balanced. Similar estimates were demonstrated when subgroup analyses were performed 
based on study quality and population type.  
 
Results in the context of the current literature 
Delirium detection remains a major challenge, with recent studies continuing to show 
underdetection [38]. An important factor in improving detection is the availability of validated 
assessment tools usable in clinical practice. The 4AT now has a substantial evidence base 
supporting its validity as a delirium assessment tool. Coupled with this is also emerging 
evidence of implementation of the 4AT scale in routine clinical practice, for example in data 
from the National Hip Fracture Database which assesses the clinical care of >95% hip fracture 
patients in England, Wales and Northern Ireland. In 2018, 25% of approximately 60,000 4AT 
assessments (92% of all patients) performed in the 7 postoperative days (the audit period) were 
positive [12]. Though diagnostic accuracy data were not collected, these data suggest that the 
4AT may be detecting the expected level of delirium. 
 Two prior systematic reviews of general delirium assessment tools included the 4AT but 
could only cite the original general validation study because of the date of the reviews [7, 8]. A 
systematic review of delirium detection in stroke patients published in 2019 included three 
studies that had evaluated the 4AT post-stroke reporting sensitivities from 0.90 to 1.00 and 
specificities from 0.65 to 0.86 [39]. 
 
  
There are many other tools in the literature; however those with profiles of intended use similar 
to the 4AT with more than two published diagnostic accuracy studies are the CAM, the 3D-
CAM, and the brief CAM (bCAM) [7, 36, 40-46]. The CAM was first published in 1990 and is a 
widely used tool in research and clinical practice. There are 23 published CAM diagnostic test 
accuracy studies involving a total of 2629 patients [11, 40], with sensitivities of 0.09-1.0 and 
specificities of 0.84-1.0 reported. There is limited published information on its performance in 
routine clinical care. One recent large study found a sensitivity of 0.27 [41] though the CAM was 
scored without the recommended preceding interview and cognitive testing. Alternative tools 
include the 3D-CAM, a 20-item variant of the CAM that takes 2-5 minutes to complete (median 
3 minutes) [42], and the bCAM, a 2 minute, 4-item variant of the CAM designed and validated 
for use in the emergency department [43]. Both of these tools show generally good 
performance in published diagnostic test accuracy studies, with reported 3D-CAM sensitivities 
of 0.85-1.0 and specificities of 0.88-0.97 [42, 47-49], and reported bCAM sensitivities of 0.65-
0.84 and specificities of 0.87-0.97 [36, 43-46]. To our knowledge there are currently no 
published clinical implementation data for these tools. 
Our review provides evidence that the 4AT has good diagnostic test accuracy for identification 
of delirium, with a body of validation data comparable to the CAM. The 4AT has some 
advantages over the CAM and 3D-CAM, being shorter and simpler, and not requiring special 
training. Notably, the 4AT had a higher sensitivity than the CAM, though with similar specificity, 
in a recent STARD-compliant randomised controlled trial [11]. As with other delirium tools, 
studies on clinical implementation of the 4AT are relatively lacking. These kinds of studies might 
expose training needs or other challenges in implementation such as lower sensitivity when 
used in routine practice. Additionally, the 4AT lacks diagnostic accuracy data in palliative care 
settings and has limited data in the community. The number of studies examining its 
performance in patients with known dementia is relatively small; the three studies presented in 
this review found lower specificity in delirium superimposed on dementia [10, 29, 35].  
  
Strengths and weaknesses of the study 
This is the first meta-analysis of 4AT diagnostic test accuracy studies. Our findings were 
broadly consistent across different care settings and languages. We published the protocol in 
advance, and we used systematic and robust methods including using a comprehensive search 
strategy, and independent reviewers to identify, select, appraise and synthesise relevant 
studies. The selected studies originated from nine countries, and eight were conducted with a 
translated version of the tool. Thus, the findings of the review suggest good generalisability. The 
methodological quality of the studies was moderate to good overall, despite some uncertainty in 
relation to the conduct of the 4AT in four studies. The two studies showing low sensitivities both 
had high risk of bias. Both prospective and retrospective studies were included to allow a review 
of the totality of evidence with regards to the diagnostic test accuracy of the 4AT. Although 
retrospective studies are highly susceptible to selection bias (potentially resulting in an 
overestimation of diagnostic odds ratio of the index test) [20, 50], sensitivity analyses based on 
quality metrics showed that the retrospective studies had little impact on the diagnostic 
accuracy estimates of the 4AT. Due to the data of the studies included in this review, it was not 
possible to perform sensitivity analyses to determine the impact of time interval between tests 
and this should be the subject of further studies. Also, the Cochrane guidelines recommend the 
use of a single reference standard in order to prevent bias or ambiguity, but we included studies 
using either DSM-IV, DSM-5 or CAM as reference standard to maximise comprehensiveness.   
  
Areas for further research 
Methodological deficiencies related to the timings of the reference standard and 4AT identified 
in this review, as well as lack of adherence to the STARD guidelines, should be addressed in 
future validation studies. Studies evaluating the 4AT in other settings and in patients with 
dementia, preferably taking into account the severity of dementia, are required. Clinical 
implementation studies evaluating 4AT performance including completion rates as well as 
diagnostic accuracy in routine clinical practice are also needed. 
  
Conclusion 
This meta-analysis quantifies the diagnostic accuracy of the 4AT. The psychometric 
performance is good and coupled with its simplicity and brevity, the present findings support 
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Study ID Country Language 
4AT 
Study design Patient 
population 




Sex Mean age 
(years) ± SD 





et al., 2018 
[33] 















over 1 year 











Chart review by 2-3 
physicians 
Administered by 
nurses every shift  
Asadollahi 
et al. 2016 
[23] 





and daily care 
centres 
















234 29 (12.4%) 64.1% 
female 
83.9 ± 6.1 Structured reference 
standard assessment, 






















28 (30.8%) 37.4% 
female 
72.5 ± 5.1 DSM-5 by trained 
reference rater 
Within 2h by 
researchers 
(blinded) 
De et al. 
2017 [29] 





























49 (15.4%) 53.3% 
female 























83.1 ± 6.7 DSM-5 by geriatrician 
(using checklist) 





Italy Italian Prospective 
study 
Stroke and TIA 
patients 
Acute stroke unit 82 out of 100 
patients 




DSM-5 by neurologist; 
diagnoses afterwards 
Same day by 
neurologist (not 
  
















acute care unit 
older patients 
Acute care units 




Center; Study 2: 
Community 
hospitals 
Study 1: 310; 
Study 2: 188 






Study 1: age 
78; 
Study 2: 80.8 
(SD not 
reported) 
Chart review tool Administered by 












24 (24.7%) 49.5% 
female 
 
73.6 ± 8.17 DSM-IV-TR (and using 
Thai Delirium Rating 
Scale) by psychiatrist 
Within 30 min by 
nurses (blinded) 
Kutlubaev 
et al., 2016 
[32] 







73 33 (45.2%) 71.2% 
female 
74 (SD not 
reported) 
DSM-IV by neurologist Patient examined 
twice at interval of 
12-24h by 
neurologist 
Lees et al. 
2013 [34] 









CAM and case notes 
extraction by medical 
student 














49 21 (42.8%) 54.2% 
female 





according to DSM-5 
using chart-based 
method (over whole 
admission, 
mean/median 
approximately 5 days, 
up to 15 days) 




et al., 2018 
[34] 















DSM-5 by geriatrician; 
use of DRS-R98, 
MMSE, IQCODE 











Recovery room 143 out of 543 
patients 
15 (10.5%)  54.6% 
female 




DSM-5 by medical 
doctors; use of CAM-
ICU 













395 out of 785 
patients 
49 (12.4%) 54.2.% 
female 
81.4 ± 6.4 DSM-5 by researchers; 
use of structured 
Within 2h by 
researchers 
  
[11] geriatric wards reference standard 
assessment including 
DRS-R98, attention 
and memory tests, and 
arousal scales 
(blinded). Order of 




Table 1: Characteristics of included studies  
Notes. CAM = Confusion Assessment Method; DSM-IV = Diagnostic and Statistical Manual of Mental Disorders, 4th edition; DSM-IV-TR = 
Diagnostic and Statistical Manual of Mental Disorders, 4th edition, Text revision; DSM-5 = Diagnostic and Statistical Manual of Mental 
Disorders, 5th edition; IQR = interquartile range; SD = standard deviation; CAM= Confusion Assessment Method; CAM-ICU = Confusion 
Assessment Method-Intensive Care Unit; DRS-R98 = Delirium Rating Scale-Revised 98; MMSE = Mini-Mental Status Examination; IQCODE = 

















risk of bias) 






























Figure 1. PRISMA flow chart diagram for the search and study selection process. PRISMA: 
Preferred Reporting Items for Systematic Reviews and Meta-Analyses. 
  
853 records identified through 
database searching
(38 Medline, 8 PsycINFO,
115 EMBASE, 495 CINAHL,































780 records after duplicates removed
780 records screened
759 records excluded on basis 
of title and/or abstract
21 full-text articles 
assessed for eligibility
5 study authors contacted 
for summary data on 
subsets of older patients
4 full-text articles excluded,      
with reasons
4AT not validated,
e.g. no reference standard or
no sensitivity reported (n=4)
3 additional records 
identified through other 
sources
17 studies
(from 16 papers) 








Figure 3. Hierarchical Summary Receiver Operating Characteristic (HSROC) curve of the 4AT 
for identifying individuals with delirium. 
  
  
Appendix 1. The 4AT 
 







for delirium &  
cognitive impairment 
 
                             (label) 
Patient name:   
 







Date:             Time: 
 
 
Tester:   
 
 
            
                              CIRCLE 
[1] ALERTNESS      
This includes patients who may be markedly drowsy (eg. difficult to rouse and/or obviously sleepy  
during assessment) or agitated/hyperactive. Observe the patient. If asleep, attempt to wake with  
speech or gentle touch on shoulder. Ask the patient to state their name and address to assist rating.   
 
     Normal (fully alert, but not agitated, throughout assessment)   0 
Mild sleepiness for <10 seconds after waking, then normal  0 




Age, date of birth, place (name of the hospital or building), current year.    
 
No mistakes      0 
     1 mistake       1 




Ask the patient: “Please tell me the months of the year in backwards order, starting at December.”  
To assist initial understanding one prompt of “what is the month before December?” is permitted. 
 
Months of the year backwards     Achieves 7 months or more correctly    0 
     Starts but scores <7 months / refuses to start   1
     Untestable (cannot start because unwell, drowsy, inattentive) 2 
 
 
[4] ACUTE CHANGE OR FLUCTUATING COURSE 
Evidence of significant change or fluctuation in: alertness, cognition, other mental function  
(eg. paranoia, hallucinations) arising over the last 2 weeks and still evident in last 24hrs  
        
      No      0 
      Yes      4 
 
 
4 or above: possible delirium +/- cognitive impairment 
1-3: possible cognitive impairment  
0: delirium or severe cognitive impairment unlikely (but 
delirium still possible if [4] information incomplete) 
 
                
                       4AT SCORE
 
 
GUIDANCE NOTES                          Version 1.2. Information and download: www.the4AT.com 
The 4AT is a screening instrument designed for rapid initial assessment of delirium and cognitive impairment. A score of 4 or more 
suggests delirium but is not diagnostic: more detailed assessment of mental status may be required to reach a diagnosis. A score of 1-3 
suggests cognitive impairment and more detailed cognitive testing and informant history-taking are required. A score of 0 does not 
definitively exclude delirium or cognitive impairment: more detailed testing may be required depending on the clinical context. Items 1-3 
are rated solely on observation of the patient at the time of assessment. Item 4 requires information from one or more source(s), eg. your 
own knowledge of the patient, other staff who know the patient (eg. ward nurses), GP letter, case notes, carers. The tester should take 
account of communication difficulties (hearing impairment, dysphasia, lack of common language) when carrying out the test and 
interpreting the score.  
 
Alertness: Altered level of alertness is very likely to be delirium in general hospital settings. If the patient shows significant altered 
alertness during the bedside assessment, score 4 for this item. AMT4 (Abbreviated Mental Test - 4): This score can be extracted from 
items in the AMT10 if the latter is done immediately before. Acute Change or Fluctuating Course: Fluctuation can occur without delirium 
in some cases of dementia, but marked fluctuation usually indicates delirium. To help elicit any hallucinations and/or paranoid thoughts 
ask the patient questions such as, “Are you concerned about anything going on here?”; “Do you feel frightened by anything or anyone?”; 
“Have you been seeing or hearing anything unusual?”  
© 2011-2014 MacLullich, Ryan, Cash  
  
  
Appendix 2: Search strategy 
 
 
MEDLINE Search terms 
 
"4 A's test".mp.  
2. "four A's Test".mp.  
3. "4 'A's Test".mp.  
4. "4 A-T".mp.  
5. "four A-T".mp.  
6. "4-A Test".mp.  
7. "4 A's scale".mp.  
8. "four 'A's test".mp.  
9. '4AT'.mp.  
10. 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9  
11. limit 10 to yr="2011 -Current"  
12. deliri$.ti,ab.  
13. (acute adj2 (confusion$ or "brain syndrome" or "brain failure" or "psycho-organic syndrome" 
or "organic psychosyndrome")).mp.  
14. (terminal$ adj restless$).mp.  
15. toxic confus$.mp.  
16. delirium/  
17. confusion/  
18. 12 or 13 or 14 or 15 or 16 or 17  
19. 11 and 18 
 
Note: The delirium search strategy was taken from: 
https://www.nice.org.uk/guidance/cg103/documents/delirium-appendix-c-search-strategies2. 
The strategies for other databases are available on request. 
  
Conference proceedings from the following professional societies were searched: Scottish 
Delirium Association (SDA); European Delirium Association (EDA); American Delirium Society 
(ADS); and Australasian Delirium Association (ADA). Members of the EDA, ADS and ADA were 
also contacted via email and twitter to identify relevant published or unpublished data.
 
Appendix 3. 
Supplementary Table S1. Assessment of methodological quality with the QUADAS-2 tool. 
 
Domain Patient selection Index test Reference standard Flow and timing 
Description Describe methods of 
patient selection: describe 
included patients (prior 
testing, presentation, 
intended use of index test 
and setting). 
Describe the index test and 
how it was conducted and 
interpreted. 
Describe the reference 
standard and how it was 
conducted and interpreted. 
Describe any patients who 
did not receive the index 
test(s) and/or reference 
standard or who were 
excluded from the 2 x 2 
table (refer to flow 
diagram): describe the time 
interval and any 
interventions between 
index test(s) and reference 
standard. 
Signalling questions 
(yes, no, unclear) 
Was a consecutive or 
random sample of patients 
enrolled? 
Were the index test results 
interpreted without 
knowledge of the results of 
Is the reference standard 
likely to correctly classify 
the target condition? 
Was there an appropriate 
interval between index 
test(s) and reference 
  
Was a case-control design 
avoided? 
Did the study avoid 
inappropriate exclusions? 
the reference standard? 
Was the person who 
administered 4AT not 
trained/not expert in 
delirium? 
Were the reference 
standard results interpreted 
without 
knowledge of the results of 
the index test? 
standard (3h maximum)? 
Did all patients receive the 
same reference standard? 
Were all patients included 
in the analysis? 
Risk of bias Could the selection of 
patients have introduced 
bias? 
Could the conduct or 
interpretation of the index 
test have introduced 
bias? 
Could the reference 








Are there concerns that 
the included patients do not 
match the review question? 
Are there concerns that 
the index test, its conduct, 
or its interpretation differ 
from the review question? 
Are there concerns that the 
target condition as defined 
by the reference standard 





Supplementary Figure. Hierarchical Summary Receiver Operating Characteristic 
(HSROC) curve analysis of the 4AT for identifying individuals with delirium: results from 
sensitivity analyses. 
 
Two sensitivity analyses were performed including 9 studies rated as low risk of bias (A) and  
excluding four retrospective studies (B). The bivariate summary estimates (solid ellipses), with 













































































Supplementary Table S2. Summary estimates of sensitivity and specificity per subgroup. 
 






Studies using a clinical reference 
standard (e.g. DSM)  




Studies using a validated 
assessment tool 








Studies using a translated version 
of the 4AT 
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